Banner image placeholder
Banner image
Menu

When genomics companies act as biobanks: governance challenges in an era of genomic assetization


Journal article


Alexis Walker
Frontiers in Genetics


Cite

Cite

APA   Click to copy
Walker, A. When genomics companies act as biobanks: governance challenges in an era of genomic assetization. Frontiers in Genetics. https://doi.org/10.3389/fgene.2026.1778236


Chicago/Turabian   Click to copy
Walker, Alexis. “When Genomics Companies Act as Biobanks: Governance Challenges in an Era of Genomic Assetization.” Frontiers in Genetics (n.d.).


MLA   Click to copy
Walker, Alexis. “When Genomics Companies Act as Biobanks: Governance Challenges in an Era of Genomic Assetization.” Frontiers in Genetics, doi:10.3389/fgene.2026.1778236.


BibTeX   Click to copy

@article{alexis-a,
  title = {When genomics companies act as biobanks: governance challenges in an era of genomic assetization},
  journal = {Frontiers in Genetics},
  doi = {10.3389/fgene.2026.1778236},
  author = {Walker, Alexis}
}


Share

Translate to